Endocannabinoids and related fatty acid derivatives in pain modulation.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Chemistry and Physics of Lipids

• Publication date

  2002-12-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-3084(02)00152-4PMID 12505698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analgesic activity of δ9-tetrahydrocannabinol in the rat and mouse

  2004cited by this paper
• Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

  2002cited by this paper
• Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.

  2002cited by this paper
• Regulation of anandamide tissue levels by N-arachidonylglycine.

  2002cited by this paper
• An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

  2002cited by this paper
• Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.

  2002cited by this paper
• Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

  2002cited by this paper
• Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

  2001cited by this paper
• Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain*

  2001cited by this paper
• 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

  2001cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.

  2001cited by this paper
• Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.

  2001cited by this paper
• Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide

  2001cited by this paper
• Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.

  2000cited by this paper
• N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

  2000cited by this paper
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

  2000cited by this paper
• Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity

  2000cited by this paper
• Oxidative metabolism of anandamide.

  2000cited by this paper
• Identification of the Role of Endogenous Cannabinoids in Pain Modulation: Strategies and Pitfalls

  2000cited by this paper
• The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

  1999cited by this paper
• Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

  1999cited by this paper
• Cannabinoid WIN 55,212-2 Inhibits the Activity-Dependent Facilitation of Spinal Nociceptive Responses

  1999cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• Pain modulation by release of the endogenous cannabinoid anandamide.

  1999cited by this paper
• Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.

  1999cited by this paper
• The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat

  1999cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.

  1999cited by this paper
• Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord.

  1999cited by this paper
• Cannabinoid receptors undergo axonal flow in sensory nerves.

  1999cited by this paper
• Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat.

  1999cited by this paper
• Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses.

  1999cited by this paper
• The effects of cannabinoids on the brain.

  1999cited by this paper
• CB1 receptor localization in rat spinal cord and roots, dorsal root ganglion, and peripheral nerve.

  1999cited by this paper
• Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors.

  1999cited by this paper
• Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine.

  1999cited by this paper
• An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

  1998cited by this paper
• Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry.

  1998cited by this paper
• Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2.

  1998cited by this paper
• Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide.

  1998cited by this paper
• Antihyperalgesic effects of spinal cannabinoids.

  1998cited by this paper
• Recovery of high potassium-evoked dopamine release after depolarization challenge in the striatum of young and old male rats.

  1998cited by this paper
• The anti‐hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

  1998cited by this paper
• Control of pain initiation by endogenous cannabinoids

  1998cited by this paper
• Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration.

  1998cited by this paper
• A Novel Neurotransmitter System Involved in the Control of Motor Behavior by the Basal Ganglia a

  1998cited by this paper
• Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.

  1998cited by this paper
• The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.

  1998cited by this paper
• Endocannabinoids.

  1998cited by this paper
• Oleamide Potentiates Benzodiazepine-Sensitive gamma-Aminobutyric Acid Receptor Activity but Does Not Alter Minimum Alveolar Anesthetic Concentration

  1998cited by this paper
• Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment.

  1998cited by this paper
• Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

  1998cited by this paper
• Anandamide may mediate sleep induction

  1997cited by this paper
• The Sleep-inducing Lipid Oleamide Deconvolutes Gap Junction Communication and Calcium Wave Transmission in Glial Cells

  1997cited by this paper
• Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide.

  1997cited by this paper
• SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

  1997cited by this paper
• Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor.

  1997cited by this paper
• The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain.

  1997cited by this paper
• Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain.

  1997cited by this paper
• Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

  1997cited by this paper
• Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

  1997cited by this paper
• Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist.

  1996cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996cited by this paper
• Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors.

  1996cited by this paper
• Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects

  1996cited by this paper
• N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.

  1996cited by this paper
• Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.

  1995cited by this paper
• Chemical characterization of a family of brain lipids that induce sleep.

  1995cited by this paper
• 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

  1995cited by this paper
• Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

  1995cited by this paper
• Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.

  1995cited by this paper
• Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2.

  1995cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• Molecular characterization of a peripheral receptor for cannabinoids

  1993cited by this paper
• Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist.

  1993cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

  1992cited by this paper
• Spinal and supraspinal components of cannabinoid-induced antinociception.

  1991cited by this paper
• Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

  1991cited by this paper
• Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism.

  1991cited by this paper
• Analgesic and antiinflammatory activity of constituents ofCannabis sativa L.

  1988cited by this paper
• The Antinociceptive Effects of Intrathecally Administered Levonantradol and Desacetyllevonantradol in the Rat

  1981cited by this paper
• A Pharmacological Analysis of Levonantradol Antinociception in Mice

  1981cited by this paper
• 9-nor-9beta-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine.

  1977cited by this paper
• Psychological and physiological mechanisms of pain.

  1977cited by this paper
• Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).

  1973cited by this paper
• Antipyretic, analgesic and anti-inflammatory effects of ?9-tetrahydrocannabinol in the rat

  1973cited by this paper
• Antipyretic, analgesic and anti-inflammatory effects of delta 9-tetrahydrocannabinol in the rat.

  1973cited by this paper
• The Pharmacology of Cannabis

  1969cited by this paper
• Pharmacological effects of two active constituents of marihuana.

  1968cited by this paper
• THE IDENTIFICATION OF N-(2-HYDROXYETHYL)-PALMITAMIDE AS A NATURALLY OCCURRING ANTI-INFLAMMATORY AGENT

  1957cited by this paper

• Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat

  2024cites this paper
• Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge

  2023cites this paper
• Spectral characterization and biological evaluation of biomolecules from the peels of three orange fruits: a comparative study.

  2023cites this paper
• Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications.

  2022cites this paper
• The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study

  2022cites this paper
• Treatment for Long-COVID-19 ? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  2022cites this paper
• Roles of Endocannabinoids and Endocannabinoid-like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective.

  2021cites this paper
• Oleamide, a Sleep-Inducing Supplement, Upregulates Doublecortin in Hippocampal Progenitor Cells via PPARα

  2021cites this paper
• Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation

  2021cites this paper
• Amazonian medicinal smokes: Chemical analysis of Burseraceae pitch (breu) oleoresin smokes and insights into their use on headache.

  2021cites this paper
• The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications

  2020cites this paper
• Cannabinoids in the descending pain modulatory circuit: Role in inflammation.

  2020cites this paper
• Characterization of cerebral cortical endocannabinoid levels in a rat inguinal surgery model using liquid chromatography–tandem mass spectrometry (LC–MS/MS)

  2019cites this paper
• The grass is not always greener: a multi-institutional pilot study of marijuana use and acute pain management following traumatic injury

  2018cites this paper
• UNIVERSITY OF SÃO PAULO FACULTY OF MEDICINE OF RIBEIRÃO PRETO Laboratory of Neuroanatomy and Neuropsychobiology Department of Pharmacology The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by th

  2018cites this paper
• The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nocicpetive tone Running title: Endocannabinoids, PAG and conditional analgesia

  2017cites this paper
• Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation

  2017cites this paper
• The Relaxation System Theoretical Construct

  2017cites this paper
• Structure, biology and chemistry of plumbago auriculata (plumbaginaceae).

  2017cites this paper
• Induction of apoptosis in human hepatocellular carcinoma cells by extracts of Lannea coromandelica (Houtt.) Merr. and Diospyros castanea (Craib) Fletcher

  2016cites this paper
• Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms

  2016cites this paper
• Carbon nanotube-anandamide complex exhibits sustained protective effects in an in vitro model of stroke

  2016cites this paper
• Mildly Increased Mechanical Nociceptive Sensitivity in REV-ERBα Knock-out Mice

  2016cites this paper
• Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.

  2016cites this paper
• Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis

  2016cites this paper
• For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders.

  2016cites this paper
• Effects of cannabinoid receptor deletion on bone marrow-derived dendritic cell subtype development, maturation and antigen loading on MHC class I

  2016cites this paper
• Molecular and cellular mechanisms that initiate pain and itch

  2015cites this paper
• Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis

  2015cites this paper
• Postnatal maturation of the opioid and endocannabinoid signalling systems within the descending pain pathway of the rat

  2015cites this paper
• Endocannabinoids modulate human blood–brain barrier permeability in vitro

  2015cites this paper
• Intracisternal injection of palmitoylethanolamide inhibits the peripheral nociceptive evoked responses of dorsal horn wide dynamic range neurons

  2015cites this paper
• Methodology for Trace and Ultratrace Analysis of Primary Amines

  2014cites this paper
• Aplicação de agonistas canabinoides na terapêutica e o seu impacto sociopolítico- económico

  2014cites this paper
• Endocannabinoid modulation of TLR4-induced neuroinflammation: implications for autism spectrum disorders

  2014cites this paper
• A review study on analgesic applications of Iranian medicinal plants.

  2014cites this paper
• Mammalian Fatty Acid Amides of the Brain and CNS

  2014cites this paper
• Kannabisaren terapia erabilera

  2014cites this paper
• Cannabinoids: Pharmacological profile of promising molecules

  2013cites this paper
• Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?

  2013influential citation
• The role of endocannabinoids in pain modulation

  2013cites this paper
• Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain.

  2013cites this paper
• Anandamide, Cannabinoid Type 1 Receptor, and NMDA Receptor Activation Mediate Non-Hebbian Presynaptically Expressed Long-Term Depression at the First Central Synapse for Visceral Afferent Fibers

  2013cites this paper
• Review of sn-2 palmitate oil implications for infant health.

  2013cites this paper
• Chapter 10 – Endocannabinoids

  2012cites this paper
• Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor.

  2012cites this paper
• Potential control of multiple sclerosis by cannabis and the endocannabinoid system.

  2012cites this paper
• Endocannabinoids and the cardiovascular response to stress

  2012influential citation
• A powerful test for multiple rare variants association studies that incorporates sequencing qualities

  2012cites this paper
• Microalgae of different phyla display antioxidant, metal chelating and acetylcholinesterase inhibitory activities

  2012cites this paper
• The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone

  2012cites this paper
• Endokannabinoidien vaikutus monosyyttien MMP-9-eritykseen

  2011cites this paper
• Anandamide and analogous endocannabinoids: a lipid self-assembly study

  2011cites this paper
• Antinociception by endogenous ligands at peripheral level.

  2011cites this paper
• The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level.

  2011cites this paper
• The effect of plant derived and endogenous substances on the spinal mechanisms of pain in rats

  2011cites this paper
• Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.

  2011cites this paper
• Oleamide and Oleamide–Lipid Mixed Monolayers

  2011cites this paper
• The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation.

  2011cites this paper
• Endocannabinoids : Marijuana from Within

  2010cites this paper
• Cannabinoids for the control of experimental multiple sclerosis

  2010cites this paper
• Peer Reviewed Title: Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level

  2010cites this paper
• Biomarkers of Endocannabinoid System Activation in Severe Obesity

  2010cites this paper
• Modulation of pain sensitivity by endogenous and exogenous ligands and by social isolation

  2010cites this paper
• Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior.

  2010cites this paper
• The effects of neurolipins and their synthetic analogues on normal and transformed glial cells

  2010cites this paper
• Inactivation of Anandamide Signaling: A Continuing Debate

  2010cites this paper
• Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level

  2010cites this paper
• Peripheral antinociceptive effects of endogenous li gands (endomorphin-1, 2-arachidonoyl glycerol and kynurenic acid) in a joint pain model

  2010influential citation
• Phytocannabinoids and endocannabinoids.

  2009cites this paper
• Endocannabinoid-mediated control of synaptic transmission.

  2009cites this paper
• Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.

  2009cites this paper
• The antinociceptive interaction of anandamide and adenosine at the spinal level.

  2009cites this paper
• Endogenous cannabinoids and neutrophil chemotaxis.

  2009cites this paper
• Non-alcoholic fatty liver disease pathogenesis: the present and the future.

  2009cites this paper
• Lipid Droplets Are Novel Sites of N-Acylethanolamine Inactivation by Fatty Acid Amide Hydrolase-2*

  2009cites this paper
• Anti‐inflammatory Effect of Palmitoylethanolamide on Human Adipocytes

  2009cites this paper
• ANTINOCICEPTIVE INTERACTIONS BETWEEN ANANDAMIDE AND ENDOMORPHIN‐1 AT THE SPINAL LEVEL

  2009cites this paper
• CB1 Receptor Antagonist AM-251: Effect on Spatial Memory in Male Mice

  2009cites this paper
• Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.

  2008influential citation
• The endocannabinoid system and multiple sclerosis.

  2008cites this paper
• The Endocannabinoid System and the Therapeutic Potential of Cannabinoids

  2007cites this paper
• Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain

  2007cites this paper
• Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis

  2007cites this paper
• Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

  2007cites this paper
• An Overview on the Biochemistry of the Cannabinoid System

  2007cites this paper
• Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

  2007cites this paper
• Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain

  2007cites this paper
• Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?

  2007cites this paper
• Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength

  2006cites this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cites this paper
• Effects of intrathecal anandamide on somatosensory evoked responses in rats.

  2006cites this paper
• Arachidonoyl amino acids and arachidonoyl peptides: Synthesis and properties

  2006cites this paper
• The endocannabinoid system in ageing: a new target for drug development.

  2006cites this paper
• Identification of the VR-1 Vanilloid Receptor in Cell Cultures

  2006cites this paper
• Behavioral methods in cannabinoid research.

  2006cites this paper
• G02 Identification of functional TRPV1 vanilloid receptor in MCF-7 cells

  2006cites this paper
• Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

  2006cites this paper
• Interaction of endogenous ligands mediating antinociception.

  2006cites this paper
• Endocannabinoids and Dopamine-Related Functions in the CNS

  2005cites this paper